| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.092 | 0.002 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |